The Effects of Intraoperative Tranexamic Acid on Perioperative Bleeding In Craniotomies

PHASE3RecruitingINTERVENTIONAL
Enrollment

102

Participants

Timeline

Start Date

April 3, 2024

Primary Completion Date

December 31, 2027

Study Completion Date

December 31, 2027

Conditions
Brain TumorBleeding
Interventions
DRUG

TRANEXAMIC ACID 1 G in 10 mL INTRAVENOUS INJECTION, SOLUTION

Tranexamic acid 20 mg/kg IV bolus within 30 minutes prior to the skin incision followed by a 1 mg/kg/hr infusion of TXA, for the duration of surgery. Treatment is blinded.

OTHER

Placebo

0.9% normal saline 20ml/kg IV bolus within 30 minutes prior to the skin incision followed by a 1 ml/kg/hr infusion of 0.9 % sodium chloride for the duration of surgery. Treatment is blinded.

Trial Locations (1)

B3H3A7

RECRUITING

Nova Scotia Health Authority- Queen Elizabeth II Health Sciences Center, Halifax

All Listed Sponsors
collaborator

Dalhousie University

OTHER

lead

Stephen Lownie

OTHER